Is Aardvark Therapeutics, Inc. Common Stock (AARD) a Buy, Sell, or Hold?
NASDAQ : AARD
Aardvark Therapeutics, Inc. Common Stock — Analyst Ratings
$7.52 USD
$0.29 (4.01%)
- Volume
- 190.61K
- Average Volume
- 263.97K
- Market Capitalization
- $164.57M
- P/E Ratio
- -2.34
- Dividend Yield
- 0.00%
- Price Target
- $4.50
- Year High
- $17.94
- Year Low
- $3.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.06
Analyst Consensus Summary
Consensus Rating
Sell
9 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
67.1%
vs Current Price
Price Target
$4.50
Average TargetPrice Target Range
Lowest Target
$3.00
150.7% UPSIDE
Average Target
$4.50
Median Estimate
Highest Target
$6.00
25.3% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 9
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 4 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Brian Abrahams | $6 | $12.49 | 2026-03-02 12:41 AM | -52.0% |
| Raymond James | Chris Raymond | $47 | $14.27 | 2026-01-12 04:47 AM | 229.4% |
| Oppenheimer | Leland Gershell | $35 | $14.55 | 2025-12-23 06:23 AM | 140.5% |
| RBC Capital | Brian Abrahams | $18 | $10.86 | 2025-11-14 04:30 AM | 65.7% |